Article Information
vol. 8 no. 1
PubMed
Published By
Online ISSN
History
- Received September 23, 2021
- Accepted November 10, 2021
- Published online February 14, 2022.
Article Versions
- previous version (December 10, 2021 - 01:42).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Luis Felipe Reyes1,2⇑,
- Srinivas Murthy3,
- Esteban Garcia-Gallo1,
- Mike Irvine4,
- Laura Merson2,
- Ignacio Martin-Loeches5,
- Jordi Rello6,
- Fabio S. Taccone7,
- Robert A. Fowler8,
- Annemarie B. Docherty2,
- Christiana Kartsonaki2,
- Irene Aragao9,
- Peter W. Barrett10,
- Abigail Beane11,
- Aidan Burrell12,
- Matthew Pellan Cheng13,
- Michael D. Christian14,
- Jose Pedro Cidade15,
- Barbara Wanjiru Citarella2,
- Christl A. Donnelly2,
- Susana M. Fernandes16,
- Craig French17,
- Rashan Haniffa11,
- Ewen M. Harrison2,
- Antonia Ying Wai Ho2,
- Mark Joseph18,
- Irfan Khan19,
- Michelle E. Kho13,
- Anders Benjamin Kildal20,
- Demetrios Kutsogiannis21,
- François Lamontagne22,
- Todd C. Lee13,
- Gianluigi Li Bassi23,
- Jose Wagner Lopez Revilla24,
- Catherine Marquis22,
- Jonathan Millar25,
- Raul Neto26,
- Alistair Nichol27,
- Rachael Parke28,
- Rui Pereira29,
- Sergio Poli30,
- Pedro Povoa15,
- Kollengode Ramanathan31,
- Oleksa Rewa21,
- Jordi Riera6,
- Sally Shrapnel23,
- Maria Joao Silva9,
- Andrew Udy12,
- Timothy Uyeki32,
- Steve A. Webb12,
- Evert-Jan Wils33,
- Amanda Rojek2 and
- Piero L. Olliaro2
- on behalf of the ISARIC Clinical Characterisation Group
- Corresponding author: Luis Felipe Reyes (luis.reyes5{at}unisabana.edu.co)
- ISARIC Clinical Characterisation Group
- 1Universidad de La Sabana, Chía, Colombia
- 2Nuffield Dept of Medicine, University of Oxford, Oxford, UK
- 3British Columbia Children's Hospital, Vancouver, BC, Canada
- 4British Columbia Centre for Disease Control, Vancouver, BC, Canada
- 5Intensive Care Medicine, St James's Hospital, Dublin, Ireland
- 6Vall d'Hebron Institute of Research, Barcelona, Spain
- 7Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 8Sunnybrook Health Sciences Centre, Toronto, ON, Canada
- 9Centro Hospitalar Universitário do Porto, Porto, Portugal
- 10Piedmont Atlanta Hospital, Atlanta, GA, USA
- 11Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
- 12Monash University, Melbourne, Australia
- 13McGill University, Hamilton, ON, Canada
- 14Bart's NHS Health Trust, London, UK
- 15Hospital São Francisco Xavier, Lisbon, Portugal
- 16Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
- 17Western Health, Melbourne, Australia
- 18Carilion Clinic, Roanoke, VA, USA
- 19Presbyterian Hospital Services, Albuquerque, NM, USA
- 20University Hospital of North Norway, Tromsø, Norway
- 21The University of Alberta, School of Medicine and Dentistry, Edmonton, AB, Canada
- 22Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
- 23University of Queensland, Brisbane, Australia
- 24Instituto Nacional del Niño San Borja, Lima, Peru
- 25Roslin Institute, University of Edinburgh, Edinburgh, UK
- 26Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
- 27St Vincent's University Hospital, Dublin, Ireland
- 28Auckland City Hospital, Auckland, New Zealand
- 29Hospital Curry Cabral, Lisbon, Portugal
- 30Mount Sinai Medical Center, Miami, FL, USA
- 31National University of Singapore, Singapore, Singapore
- 32Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA
- 33Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands
Funding
Wellcome
215091/Z/18/ZBill and Melinda Gates Foundation
OPP1209135Canadian Institutes of Health Research
OV2170359Foreign, Commonwealth and Development Office
215091/Z/18/Z
Article usage
Altmetrics
Vol 8 Issue 1
Table of Contents
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
